IPCA Labs Fact Sheet, IPCA Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Fact Sheet    (IPLB)


REVEALED: Brijesh Bhatia's Private Telegram Channel (JOIN NOW)


Here is the latest financial fact sheet of IPCA Labs. For more details, see the IPCA Labs quarterly results and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

IPCA LABS Price History

Price Rs 2,101.9
Mkt Cap Rs m 266,624
Vol '000 5.4
P/E X 23.2
P/CF X 32.4
EPS (TTM) Rs 90.6
% ch % -1.9
No. of shares m 126.85
% ch week % -3.5
% ch 1-mth % 3.9
% ch 12-mth % 18.3
52 week H/L Rs 2,455.6/1,740.4
(As on Jul 30, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IPCA LABS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
IPCA LABS EQUITY SHARE DATA
High Rs8886436951,0421,616 
Low Rs525402400590844 
Sales per share (Unadj.) Rs224.1245.7256.1294.3363.2 
Earnings per share (Unadj.) Rs7.616.119.335.148.4 
Diluted earnings per shareRs7.616.019.235.048.2 
Cash flow per share (Unadj.) Rs20.629.833.449.665.0 
Dividends per share (Unadj.) Rs01.001.003.005.00 
Adj. dividends per shareRs0.000.990.992.994.98 
Dividend yield (eoy) %00.20.20.40.4 
Book value per share (Unadj.) Rs179.0194.6213.0247.1286.2 
Adj. book value per shareRs178.1193.6211.9246.1285.0 
Shares outstanding (eoy) m126.20126.20126.20126.35126.35 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.22.12.12.83.4 
Avg P/E ratio x92.732.528.423.225.4 
P/CF ratio (eoy) x34.417.516.416.518.9 
Price / Book Value ratio x3.92.72.63.34.3 
Dividend payout %06.25.28.510.3 
Avg Mkt Cap Rs m89,16065,93969,119103,110155,407 
No. of employees `000NANANANANA 
Total wages/salary Rs m6,2566,9607,3597,8749,212 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
IPCA LABS INCOME DATA
Net Sales Rs m28,27731,00232,32037,18245,894 
Other income Rs m408548581747865 
Total revenues Rs m28,68531,54932,90037,92946,759 
Gross profit Rs m2,7374,1544,4206,7838,905 
Depreciation Rs m1,6331,7301,7771,8242,105 
Interest Rs m346269276222198 
Profit before tax Rs m1,1662,7032,9485,4837,467 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2046755111,0421,353 
Profit after tax Rs m9622,0282,4374,4406,114 
Gross profit margin %9.713.413.718.219.4 
Effective tax rate %17.525.017.319.018.1 
Net profit margin %3.46.57.511.913.3 
IPCA LABS BALANCE SHEET DATA
Current assets Rs m16,21917,41819,45523,77828,557 
Current liabilities Rs m9,7009,55910,07610,97513,264 
Net working cap to sales %23.125.329.034.433.3 
Current ratio x1.71.81.92.22.2 
Inventory Days Days1630242536 
Debtors Days Days5859686771 
Net fixed assets Rs m22,69822,17721,70121,71124,021 
Share capital Rs m252252252253253 
"Free" reserves Rs m22,34024,30026,63030,97135,903 
Net worth Rs m22,59224,55326,88331,22436,155 
Long term debt Rs m4,8433,5172,3401,4091,030 
Total assets Rs m38,91739,59541,15645,48852,578 
Interest coverage x4.411.011.725.738.8 
Debt to equity ratio x0.20.10.100 
Sales to assets ratio x0.70.80.80.80.9 
Return on assets %3.45.86.610.312.0 
Return on equity %4.38.39.114.216.9 
Return on capital %5.510.611.017.520.6 
Exports to sales %48.40000 
Imports to sales %8.50000 
Exports (fob) Rs m13,7000000 
Imports (cif) Rs m2,4140000 
Fx inflow Rs m13,74415,61715,64217,30821,438 
Fx outflow Rs m4,4454,5714,8846,2669,022 
Net fx Rs m9,29911,04610,75911,04212,415 
IPCA LABS CASH FLOW
From Operations Rs m 7,087 2,819 3,411 5,010 5,643 
From Investments Rs m -2,183 -1,488 -1,354 -1,651 -5,097 
From Financial Activity Rs m -4,615 -1,591 -1,304 -1,832 -1,305 
Net Cashflow Rs m 288 -260 753 1,528 -755 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 46.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 42.9%
FIIs 17.8%
ADR/GDR 0.0%
Free float 53.7%
Shareholders 105,428
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 48 Kandivli Industrial Estate, Kandivli (West), Mumbai - 400067
E-MAIL investors@ipca.co.in WEB www.ipcalabs.com
TEL 022- 66474444 FAX 022- 28686613
SECTOR PHARMACEUTICALS GROUP Ipca Laboratories Group
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
AUDITOR Natvarlal Vepari & Co.
CHM: Premchand Godha (MD) COMP SEC: Harish P. Kamath (VP - Legal) YEAR OF INC: 1949 BSE CODE: 524494 FV (Rs): 2 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   NATCO PHARMA  LINCOLN PHAR  FERMENTA BIOTECH  PHARMAIDS PH  LACTOSE INDIA  

Compare IPCA LABS With:   NATCO PHARMA  LINCOLN PHAR  FERMENTA BIOTECH  PHARMAIDS PH  LACTOSE INDIA  




Today's Market

Sensex Ends 66 Points Lower; Bajaj Finance and Bajaj Finserv Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

OPEC & Our Next Crude Oil Trade (Fast Profits Daily)

Jul 20, 2021

This is why we are on the correct side of the crude oil trade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - CONCORD DRUGS COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS